(Q27974087)

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

12 September 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase

25 September 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

15 December 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

19 December 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

20 December 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

20 December 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

20 December 2018

1 reference

glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative

20 December 2018

0 references

0 references

7

Katja Becker

0 references

author name string

Esther Jortzik

1

0 references

Boniface M Mailu

2

0 references

Janina Preuss

3

0 references

Marina Fischer

4

0 references

Lars Bode

5

0 references

Stefan Rahlfs

Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment

6

0 references

language of work or name

English

0 references

publication date

15 June 2011

0 references

published in

Biochemical Journal

0 references

volume

436

0 references

page(s)

641-50

0 references

issue

3

0 references

cites work

1 reference

On the origin and functions of RNA-mediated silencing: from protists to man

22 April 2017

1 reference

What is the role of the second "structural" NADP+-binding site in human glucose 6-phosphate dehydrogenase?

22 April 2017

1 reference

Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency

22 April 2017

1 reference

NMR spectroscopic analysis of the first two steps of the pentose-phosphate pathway elucidates the role of 6-phosphogluconolactonase

22 April 2017

1 reference

Chemical genetics of Plasmodium falciparum

22 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Glucose-6-phosphate dehydrogenase deficiency and malaria.

22 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Erythrocyte variants and the nature of their malaria protective effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Expression and characterization of glucose-6-phosphate dehydrogenase of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Cloning of the glucose 6-phosphate dehydrogenase gene from Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase. A novel bifunctional enzyme in malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Plasmodium falciparum glucose-6-phosphate dehydrogenase (G6PD)-the N-terminal portion is homologous to a predicted protein encoded near to G6PD in Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

A unique insertion in Plasmodium berghei glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: evolutionary and functional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Transient silencing of Plasmodium falciparum bifunctional glucose-6-phosphate dehydrogenase- 6-phosphogluconolactonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

No miRNA were found in Plasmodium and the ones identified in erythrocytes could not be correlated with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Interference with redox-active enzymes as a basis for the design of antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Blood cell phosphogluconolactonase: assay and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Glucose-6-phosphate dehydrogenase activity of the malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Recombinant human glucose-6-phosphate dehydrogenase. Evidence for a rapid-equilibrium random-order mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Kinetic properties of normal human erythrocyte glucose-6-phosphate dehydrogenase dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Molecular mechanisms and clinical implications of reversible protein S-glutathionylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170

Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110170